Gallbladder Disease & GLP-1 Medications

The gallbladder stores bile produced by the liver. GLP-1 medications can disrupt bile flow and composition, leading to gallstone formation (cholelithiasis). Gallstones can block bile ducts, causing intense right-upper abdominal pain, nausea, vomiting, fever, and jaundice.

When gallstones cause inflammation of the gallbladder wall (cholecystitis), emergency surgery is often required. Cholecystectomy — complete removal of the gallbladder — is one of the most common surgical consequences reported by GLP-1 users. Rapid weight loss associated with these medications further increases gallstone risk.

The FDA's prescribing information for semaglutide and tirzepatide includes gallbladder-related warnings, but lawsuits allege the manufacturers failed to adequately communicate the severity and frequency of these complications. Clinical trial data showed elevated gallbladder event rates, which plaintiffs argue were minimized in labeling.

Gallbladder removal is a major abdominal surgery with its own risks and permanent consequences. Without a gallbladder, patients may experience chronic digestive issues including bile acid diarrhea, difficulty digesting fatty foods, and postcholecystectomy syndrome.

Hospitalization records, surgical reports, and follow-up documentation strengthen claims. Emergency cholecystectomy cases are particularly strong because they demonstrate acute harm requiring immediate medical intervention.